Q3 FY2026 saw resilient margins despite revenue and profit declines, with strong export contributions and increased performance chemicals share. Capex focused on capacity expansion and new product commercialization, supporting long-term growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.